When a Trial Says No: Hydrogen Water and Parkinson's

Good science publishes its disappointments, not just its wins. If we only ever showed you positive studies, we'd be doing marketing, not honesty. So here is a rigorous trial where hydrogen water simply didn't deliver.

What the trial did

Researchers ran a double-blind, randomised, placebo-controlled trial — the gold standard — testing hydrogen-rich water against placebo water in people with Parkinson's disease, over many months, using standard clinical rating scales to measure change.

What they found

The trial did not meet its primary endpoint. Hydrogen water did not significantly outperform placebo. An earlier, much smaller pilot had hinted at a benefit; the larger, more rigorous trial did not confirm it.

This is how science is supposed to work: a promising early signal, put to a proper test, that doesn't hold up. The rigorous result overrules the hopeful one.

The honest take

We include this study deliberately. Hydrogen water is not a treatment for Parkinson's disease, or for any other illness — and a strong, well-run trial says so directly. Anyone who points to the small early pilot while ignoring the larger negative trial is telling you half the story. Kangen Water® is drinking water; it is not a medicine, and there are no authorised EU health claims for it.